Evidence map›Paper›PMID 33888678›Full record

ArticleTranslational psychiatry2021

Pharmacological modulation of AMPA receptors rescues specific impairments in social behavior associated with the A350V Iqsec2 mutation.

Renad Jabarin, Nina Levy, Yasmin Abergel, Joshua H Berman, Amir Zag, Shai Netser, Andrew P Levy, Shlomo Wagner

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Rescue ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Roles of AMPA receptors in social behaviors.Frontiers in synaptic neuroscience · 2024
    Review
  10. Article
  11. Molecular Insights into IQSEC2 Disease.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Renad Jabarin *Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Nina Levy *Technion Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Yasmin AbergelSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.ORCID 0000-0002-9822-2298
Joshua H BermanSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.ORCID 0000-0002-4528-7813
Amir ZagTechnion Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Shai NetserSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Andrew P LevyTechnion Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. alevy@technion.ac.il.
Shlomo WagnerSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel. shlomow@research.haifa.ac.il.ORCID 0000-0002-7618-0752
University of Haifa · ILTechnion – Israel Institute of Technology · IL

Funding

Human Frontier Science Program (HFSP) RGP0019/2015Israel Science Foundation (ISF) 1350/12Israel Science Foundation (ISF) 1361/17Ministry of Science, Technology and Space 3-12068
6 · The paper itself

Abstract

In this study we tested the hypothesis that pharmacological modulation of glutamatergic neurotransmission could rescue behavioral deficits exhibited by mice carrying a specific mutation in the Iqsec2 gene. The IQSEC2 protein plays a key role in glutamatergic synapses and mutations in the IQSEC2 gene are a frequent cause of neurodevelopmental disorders. We have recently reported on the molecular pathophysiology of one such mutation A350V and demonstrated that this mutation downregulates AMPA type glutamatergic receptors (AMPAR) in A350V mice. Here we sought to identify behavioral deficits in A350V mice and hypothesized that we could rescue these deficits by PF-4778574, a positive AMPAR modulator. Using a battery of social behavioral tasks, we found that A350V Iqsec2 mice exhibit specific deficits in sex preference and emotional state preference behaviors as well as in vocalizations when encountering a female mouse. The social discrimination deficits, but not the impaired vocalization, were rescued with a single dose of PF-4778574. We conclude that social behavior deficits associated with the A350V Iqsec2 mutation may be rescued by enhancing AMPAR mediated synaptic transmission.

Indexed as

Receptors, AMPASocial BehaviorAnimalsFemaleGuanine Nucleotide Exchange FactorsMiceMutationNerve Tissue ProteinsSynapsesSynaptic TransmissionGuanine Nucleotide Exchange FactorsIQSEC2 protein, mouseNerve Tissue ProteinsReceptors, AMPA

Identifiers

PMID33888678
PMCPMC8062516
OpenAlexW3152525723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.